SEPTInvestingStart Free

MDCX 10-Q: SEC filing

Medicus Pharma Ltd.

Filed with the SEC on · accession 0001062993-26-005803

MDCX filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Medicus Pharma Ltd. filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The stock moved +2.2% by the first close after the filing.

Summary of the filing

Medicus Pharma Ltd. filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and procedures.

For details, click here →How to read a 10-Q →

Key details

RegistrantMedicus Pharma Ltd.
Executive chairman and chief executive officer (principal executive officer)Dr. Raza Bokhari

How MDCX stock reacted

Close before

$1.83

Nov 5, 2026

First close after

+2.19%

$1.87

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDCX?

Click here

Frequently asked questions

What did MDCX file with the SEC on Nov 6, 2026?

MDCX filed a 10-Q (SEC filing). Medicus Pharma Ltd. filed a Form 10-Q quarterly report for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the accuracy of the financial statements and the effectiveness of disclosure controls and procedures.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did MDCX stock react to this filing?

MDCX closed at $1.83 before the filing and $1.87 on Nov 6, 2026 (+2.19%).

Other MDCX SEC filings

Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MDCX overviewMDCX analysisMDCX newsLatest SEC filings